Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Carcinoma × aldesleukin × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Brain Neoplasms 1

Interventions

fludarabine 1 aldesleukin 1 adavosertib 1 Oncolytic Virotherapy 1 Interleukin-2 1 Cyclophosphamide 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05141474 2024-11-07

NEXTGENTIL-ACT

Vall d'Hebron Institute of Oncology

Phase EARLY_PHASE1 Recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡